Multiple myeloma and Toxoplasmosis

Summary:

Toxoplasmosis is found among people with Multiple myeloma, especially for people who are male, 50-59 old.

The study analyzes which people have Toxoplasmosis with Multiple myeloma. It is created by eHealthMe based on reports of 14 people who have Multiple myeloma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,107 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

What is Toxoplasmosis?

Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii) is found to be associated with 152 drugs and 251 conditions by eHealthMe. Check the latest studies of Toxoplasmosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14 people who have Multiple Myeloma and Toxoplasmosis are studied.

Would you have Toxoplasmosis when you have Multiple myeloma?

Gender of people who have Multiple Myeloma and experienced Toxoplasmosis *:

female: 46.15 %
male: 53.85 %

Age of people who have Multiple Myeloma and experienced Toxoplasmosis *:

Common co-existing conditions for these people *:

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 14.29%
Bone Marrow Conditioning Regimen: 2 people, 14.29%
Adverse Event: 1 person, 7.14%

Common drugs taken by these people *:

Cyclophosphamide: 4 people, 28.57%
Dexamethasone: 3 people, 21.43%
Pomalidomide: 3 people, 21.43%
Lenalidomide: 3 people, 21.43%
Melphalan: 2 people, 14.29%
Revlimid: 2 people, 14.29%
Prednisolone: 2 people, 14.29%
Pentamidine Isethionate: 2 people, 14.29%
Methotrexate: 2 people, 14.29%
Melphalan Hydrochloride: 2 people, 14.29%

Common symptoms for these people *:

Gastrointestinal Infection (infection of stomach and intestine): 4 people, 28.57%
Bone Marrow Failure: 3 people, 21.43%
Confusional State: 3 people, 21.43%
Respiratory Tract Infection: 3 people, 21.43%
Neutropenic Colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition): 3 people, 21.43%
Multi-Organ Failure (multisystem organ failure): 2 people, 14.29%
Hepatic Function Abnormal: 2 people, 14.29%
Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 2 people, 14.29%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 14.29%
Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Toxoplasmosis?

- Check whether Toxoplasmosis is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Multiple myeloma (516,725 reports)
Toxoplasmosis (2,082 reports)

All the drugs that are associated with Toxoplasmosis:

Toxoplasmosis (152 drugs)

All the conditions that are associated with Toxoplasmosis:

Toxoplasmosis (251 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Toxoplasmosis and Multiple myeloma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.